CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended	141 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022	Sep. 30, 2023
Cash flows from operating activities
Net increase in net assets resulting from operations	$ (2,397,390)	$ 3,955,529	$ 6,049,800	$ 10,513,540
Adjustments to reconcile net increase in net assets from operations to net cash used in operating activities:
Purchases of investments			(139,650,422)	(180,956,810)
Proceeds from sales and repayments of investments			79,053,967	74,385,466
Net change in unrealized depreciation on investments	13,793,320	4,798,980	24,338,195	12,810,173
Net change in unrealized depreciation on foreign currency translations			21,087	28,405
Increase in investments due to PIK			(2,732,530)	(1,010,061)
Amortization of premium and accretion of discount, net			(2,078,183)	(1,839,720)	$ (2,519,462)
Deferred tax provision	312	(30,535)	144,425	151,278
Amortization of loan structure fees			436,257	420,356
Amortization of deferred financing costs			334,122	334,122
Amortization of loan fees on SBA-guaranteed debentures			938,247	905,294
Net realized gain on investments			(324,782)	(4,658,817)
Changes in other assets and liabilities
Increase in interest receivable			(1,615,612)	(907,787)
Increase in other receivables			(26,250)	(5,743)
Increase in related party receivables				(19,034)
Decrease in prepaid expenses			517,512	293,135
(Decrease) increase in management fees payable			(3,217,286)	3,578,496
Increase in income incentive fees payable			594,142	160,521
Decrease in capital gains incentive fees payable			(569,528)	(1,672,549)
Increase (decrease) in administrative services payable			45,708	(9,481)
Decrease in interest payable			(3,324,507)	(2,808,314)
Decrease in related party payable			(1,060,321)
Increase (decrease) in unearned revenue			22,535	(185,171)
Decrease in income tax payable			(59,004)	(2,183,176)
(Decrease) increase in other accrued expenses and liabilities			(272,305)	59,623
Net Cash Used in Operating Activities			(42,434,733)	(92,616,254)
Cash flows from Financing Activities
Proceeds from the issuance of common stock			63,348,436	420,004		$ 341,671,926
Sales load for common stock issued			(943,248)	(5,957)
Offering costs paid for common stock issued			(225,085)	(335,953)
Stockholder distributions paid			(22,663,688)	(17,708,494)
Proceeds from SBA-guaranteed debentures			11,400,000	56,000,000
Financing costs paid on SBA-guaranteed debentures			(277,590)	(1,363,600)
Financing costs paid on Credit facility			(35,000)	(193,659)
Borrowings under Credit Facility			79,700,000	121,608,702
Repayments of Credit Facility			(116,701,700)	(97,559,902)
Net Cash Provided by Financing Activities			13,602,125	60,861,141
Net Decrease in Cash and Cash Equivalents			(28,832,608)	(31,755,113)
Cash and Cash Equivalents Balance at Beginning of Period			48,043,329	44,174,856	44,174,856
Cash and Cash Equivalents Balance at End of Period	$ 19,210,721	$ 12,419,743	19,210,721	12,419,743	$ 48,043,329	$ 19,210,721
Supplemental and Non-Cash Activities
Cash paid for interest expense			25,653,343	18,012,797
Income and excise tax paid			1,141,061	3,249,944
Increase in dividends payable			3,215,948	1,043,498
(Decrease) increase in deferred offering costs			$ (1,100)	$ 227,109